AXA S.A. announces filing of amendment No. 1 to AXA US registration statement
for Initial Public Offering
AXA S.A. ("AXA") today announced the filing by AXA Equitable Holdings, Inc.
("AEH"), AXA's wholly-owned U.S. holding company, of Amendment No. 1 to the
registration statement on Form S-1 with the U.S. Securities and Exchange
Commission ("SEC") relating to the proposed initial public offering ("IPO") and
U.S. listing of AEH common stock. The offering is expected to consist of a
minority stake in AEH's common stock, to be sold by AXA as selling stockholder.
AXA anticipates that the IPO will occur in the second quarter of 2018. There
can be no assurance that the IPO will be completed on the expected timeline or
The shares will be offered by a group of underwriters led by Morgan Stanley &
Co. LLC and J.P. Morgan Securities LLC, with Barclays Capital Inc. and
Citigroup Global Markets Inc. also acting as underwriters for the offering. The
number of shares to be offered and the price range for the proposed offering
have not yet been determined.
A registration statement relating to the proposed IPO has been filed with the
SEC but has not yet become effective. These securities may not be sold nor may
offers to buy be accepted prior to the time the registration statement becomes
effective. This press release does not constitute an offer to sell or the
solicitation of an offer to buy securities, and shall not constitute an offer,
solicitation or sale in any jurisdiction in which such offer, solicitation or
sale would be unlawful prior to registration or qualification under the
securities laws of that jurisdiction.
ABOUT THE AXA GROUP
The AXA Group is a worldwide leader in insurance and asset management, with
165,000 employees serving 107 million clients in 64 countries. In 2016, IFRS
revenues amounted to Euro 100.2 billion and IFRS underlying earnings to Euro
5.7 billion. AXA had Euro 1,429 billion in assets under management as of
December 31, 2016.
The AXA ordinary share is listed on compartment A of Euronext Paris under the
ticker symbol CS (ISN FR 0000120628 - Bloomberg: CS FP - Reuters: AXAF.PA).
AXA's American Depository Share is also quoted on the OTC QX platform under the
ticker symbol AXAHY.
The AXA Group is included in the main international SRI indexes, such as Dow
Jones Sustainability Index (DJSI) and FTSE4GOOD.
It is a founding member of the UN Environment Programme's Finance Initiative
(UNEP FI) Principles for Sustainable Insurance and a signatory of the UN
Principles for Responsible Investment.
This press release and the regulated information made public by AXA pursuant to
article L. 451-1-2 of the French Monetary and Financial Code and articles 222-1
et seq. of the Autorité des marchés financiers' General Regulation are
available on the AXA Group website.
THIS PRESS RELEASE IS AVAILABLE ON THE AXA GROUP WEBSITE
SRI ratings: axa.com/en/investor/sri-ratings-ethical-indexes
ABOUT AXA EQUITABLE HOLDINGS
AXA Equitable Holdings is one of America's leading financial services companies
and has helped clients prepare for their financial futures since 1859. The
Company's approximately 12,000 employees and advisors are entrusted with more
than $600 billion of assets under management through two complementary and
well-established principal franchises, AXA Equitable Life and
* Advice and solutions for helping Americans set and meet their retirement
goals and protect and transfer their wealth across generations; and
* A wide range of investment management insights, expertise and innovations to
drive better investment decisions and outcomes for clients and institutional
The Company aims to be a trusted partner to its clients by providing advice,
products and services that help them navigate complex financial decisions and
face the future with confidence.
FOR MORE INFORMATION:
Kevin Molloy: +1.212.314.2893
Gina Tyler: +1.212.314.2010
IMPORTANT LEGAL INFORMATION AND CAUTIONARY STATEMENTS CONCERNING
Certain statements contained herein may be forward-looking statements
including, but not limited to, statements that are predictions of or indicate
future events, trends, plans, expectations or objectives. Undue reliance should
not be placed on such statements because, by their nature, they are subject to
known and unknown risks and uncertainties and can be affected by other factors
that could cause AXA's actual results to differ materially from those expressed
or implied in the forward-looking statements. Please refer to Part 4 - "Risk
factors and risk management" of AXA's Registration Document for the year ended
December 31, 2016, for a description of certain important factors, risks and
uncertainties that may affect AXA's business and/or results of operations. AXA
undertakes no obligation to publicly update or revise any of these
forward-looking statements, whether to reflect new information, future events
or circumstances or otherwise, except as part of applicable regulatory or legal
This press release does not constitute an offer to the public in France, nor a
prospectus within the meaning of Directive 2003/71/EC of the European
Parliament and the Council of 4 November 2003, as amended, in particular by
Directive 2010/73/EU to the extent such Directive has been transposed in the
relevant member State of the European Economic Area (together, the "Prospectus
Directive"). With respect to each Member State of the European Economic Area
which has implemented the Prospectus Directive (the "Member State"), no action
has been undertaken or will be undertaken to make an offer to the public of
securities requiring a publication of a prospectus in any Member State. As used
in this paragraph, the expression "offer to the public" in relation to any
securities in a given Member State means any communication to persons in any
form and by any means, presenting sufficient information on the terms of the
offer and the securities to be offered, so as to enable an investor to decide
to purchase or subscribe for these securities, as this definition be varied in
that Member State by any measure implementing the Prospectus Directive in that
Member State, and includes any relevant implementing measure in each Member
State. These selling restrictions with respect to Member States apply in
addition to any other selling restrictions which may be applicable in the
Member States who have implemented the Prospectus Directive.